Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23482644 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects
Condition: Variola Major (Smallpox)
Interventions: Drug: Placebo;   Biological: MVA-BN

Indicates status has not been verified in more than two years